When was Cefaly Technology founded?

Cefaly Technology was founded in 2005.

Where is Cefaly Technology located?

Cefaly Technology is headquartered in Herstal, Belgium.

Who is the current CEO of Cefaly Technology?

Pierre Rigaux of Cefaly Technology.

How many employees does Cefaly Technology have?

As of Dec 31, 2020, the latest employee count at Cefaly Technology is 8.

What is the annual revenue of Cefaly Technology?

Annual revenue of Cefaly Technology is between €10M and €50M as on Dec 31, 2024

Where does Cefaly Technology rank among its competitors?

Cefaly Technology ranks 6th amongst 40 active competitors, of which 9 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was AURIMOD, which secured an undisclosed amount in Sep, 2025.

Who are the top competitors of Cefaly Technology?

Cefaly Technology's top competitors include Salvia BioElectronics, eNeura and ShiraTronics. Among them, AURIMOD secured the most recent funding round in September, 2025.

Cefaly Technology - 2026 Company Profile, Team, Competitors & Financials

Cefaly Technology is an acquired company based in Herstal (Belgium), founded in 2005. It operates as a Neurostimulation devices for the treatment of a migraine and other headaches. The company has 40 active competitors, including 9 funded and 3 that have exited. Its top competitors include companies like Salvia BioElectronics, eNeura and ShiraTronics.

Company Details

Cefaly Technology develops neurostimulation devices for the treatment of a migraine and other headaches. The company has developed Cranial Nerve Stimulator (it is based on external trigeminal nerve stimulation and supraorbital transcutaneous nerve stimulation for migraine treatment), CEFALY t-DCS (a small, portable transcranial neurostimulator based on t-DCS), and Biofeedback system (records the action potential of the head muscles through an electrode placed on the forehead and has visual and auditory feedback mechanism).

Website: cefalytechnology.com
Phone Number: +32 **********

Key Metrics

Founded Year

2005

Location

Herstal, Belgium

Stage

Acquired

Ranked

6^th among 40 active competitors

Annual Revenue

€10M - €50M as on Dec 31, 2024

Employee Count

8 as on Dec 31, 2020

Similar Companies

Salvia BioElectronics & 34 more

Exit Details

Acquired by DW Management Services (Aug 08, 2019)

View Cefaly Technology's full profile

Cefaly Technology is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
CEFALY Technology CIN: 0870.578.661 , Belgium, Active	Dec 12, 2004	€10M - €50M (As on Dec 31, 2024)	12 (As on Dec 31, 2020)	-

Cefaly Technology got acquired by DW Management Services on Aug 08, 2019.

Click here to take a look at Cefaly Technology's acquisition in detail

Cefaly Technology has not raised any funding rounds yet.

Cefaly Technology's employee count trend

Cefaly Technology has 8 employees as of Dec 20. The total employee count is 47.0% lower than what it was in Dec 19. Here is Cefaly Technology's employee count trend over the years:

Employee count trend for Cefaly Technology

Uncover Cefaly Technology's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cefaly Technology include Salvia BioElectronics, eNeura and ShiraTronics. Here is the list of Top 10 competitors of Cefaly Technology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Salvia BioElectronics 2017, Eindhoven (Netherlands), Series B	Developing bioelectronic solutions for individuals suffering from migraines and other neurological disorders	$88.4M	Panakes Partners, Innovation Industries & 11 others	45/100
2nd	eNeura 2000, Baltimore (United States), Series D	Developer of a transcranial magnetic stimulation device for pain relief	$70.5M	Camden Partners, Domain Associates & 3 others	43/100
3rd	ShiraTronics 2019, Minneapolis (United States), Series B	Developer of a neuromodulating device for treating migraine	$108M	Norwest, Amzak Health & 9 others	41/100
4th	Zosano Pharma 2006, Fremont (United States), Deadpooled	Developer of transdermal drug delivery systems for a broad range of therapeutic indications	$147M	Nomura, ProQuest Investments & 9 others	36/100
5th	Gate Science 2020, Boston (United States), Seed	Developer of a multi-modal device for post-surgery pain	$150K	-	35/100
6th	Cefaly Technology 2005, Herstal (Belgium), Acquired	Neurostimulation devices for the treatment of a migraine and other headaches	-	-	34/100
7th	Nocira 2014, Tempe (United States), Series A	Developing a non-invasive migraine treatment device using gentle air pressure	$3.9M	AZCrown, Padda health	33/100
8th	Realeve 2020, Mountain View (United States), Series A	Developer of a device for the treatment of cranial autonomic disorders	$3M	-	30/100
9th	AURIMOD 2015, Vienna (Austria), Seed	Developer of a medical device for the treatment of pain	-	Convergence Partners, ILUM Tec	29/100
10th	Chordate 2005, Kista (Sweden), Unfunded	Developer of a medical device for the treatment of migraine	-	-	28/100